January 4, 2021 – Haven, the healthcare joint venture of Amazon, JP Morgan Chase, and Berkshire Hathaway, is disbanding after only three years.
Haven will end its independent operations at the end of February 2021.
The joint venture was announced with much fanfare at the beginning of 2018. But after three years without any major announcements or apparent breakthroughs in lowering healthcare costs and improving outcomes, the company said it is disbanding.
Initially, the venture had named Atul Gawande, a doctor and leading writer and thinker on healthcare, as its CEO, but he departed in May 2020, a move that raised questions about the direction of the company at the time.
In a statement posted on its website, the company announced that, “In the past three years, Haven explored a wide range of healthcare solutions, as well as piloted new ways to make primary care easier to access, insurance benefits simpler to understand and easier to use, and prescription drugs more affordable.
“Moving forward, Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. will leverage these insights and continue to collaborate informally to design programs tailored to address the specific needs of their own employee populations.”